Drug Type Small molecule drug |
Synonyms TAY R1 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Epidermolysis Bullosa Dystrophica | Preclinical | United Kingdom | 01 Apr 2025 | |
Neoplasms | Preclinical | United Kingdom | 10 May 2024 |